Jake Lang was charged with storming the U.S. Capitol on Jan. 6 and repeatedly assaulting police. Credit: U.S. Department of Justice Right-wing provocateur and avowed racist Jake Lang arrived in ...
Based on its trailer, this Chinese movie based on the maestro’s memoir looks like a manic, absurdist romp — but will it ever be shown in the U.S.? By Benjamin Svetkey and Julian Sancton, Editors ...
Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...
The American poet Violet Ranney Lang was born in 1924 and died in 1956, of Hodgkin’s lymphoma, at the age of thirty-two. Although last year marked the centenary of her birth, the occasion passed ...
The fate of a once-promising cancer treatment now looks uncertain at best. The meeting was conducted with U.S. Food and Drug Administration (FDA) officials, and it took place on Tuesday. The subject ...
A behind-the-scenes blog about research methods at Pew Research Center. For our latest findings, visit pewresearch.org. Every survey finding published by Pew Research ...
Replimune (NASDAQ:REPL) climbed more than 100% on Wednesday as Cantor Fitzgerald upgraded the cancer drug developer, citing a potential reversal of an FDA decision that rejected its lead drug ...
Despite a sharp drop in the previous session following the FDA rejection of its skin cancer drug RP1, Replimune (NASDAQ:REPL) shares bounced back on Wednesday even as multiple Wall Street analysts ...
NEW YORK--(BUSINESS WIRE)--Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Replimune Group, Inc. (NASDAQ: REPL) for potential violations of the federal ...
Replimune Group, Inc. (NASDAQ:REPL) stock plunged on Tuesday after a U.S. Food and Drug Administration (FDA) update. The clinical stage biotechnology company received an FDA Complete Response Letter ...
Multiple analysts have issued price targets for $REPL recently. We have seen 4 analysts offer price targets for $REPL in the last 6 months, with a median target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback